ISRG appears undervalued, trading 30.4% below estimated fair value.
ISRG fair value assessment
ISRG appears undervalued, trading 30.4% below estimated fair value.
Reality vs. Belief
ISRG's narrative runs slightly ahead of its fundamentals, but stays within a defensible range.
ISRG signal snapshot
ISRG projected price & trade signal
What's driving ISRG's price
The story driving ISRG right now: Intuitive Surgical's stock fell 30% in 2026 due to the arrival of a rival, indicating potential future price movements. High volatility-momentum readings (100) indicate significant narrative-driven price displacement.
Market Prism's verdict on ISRG
Market Prism classifies ISRG as Structurally Supported — the narrative is backed by verifiable fundamental data, not just momentum. Narrative energy is moderating at 50%, an early sign of fatigue.
Valuation outlook for ISRG
Structural support means recent weakness reads more like noise than a regime change. The story still has a foundation under it. The 30.4% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Frequently asked questions
Is ISRG overvalued right now?
ISRG appears undervalued, trading 30.4% below estimated fair value.
What is Market Prism's verdict on ISRG?
Market Prism classifies ISRG as Structurally Supported — the narrative is backed by verifiable fundamental data, not just momentum. Narrative energy is moderating at 50%, an early sign of fatigue.
What happens next for ISRG?
Structural support means recent weakness reads more like noise than a regime change. The story still has a foundation under it. The 30.4% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Is ISRG a good value investment?
Market Prism does not provide investment recommendations. Our forensic analysis shows: ISRG is structurally supported, trading 30.4% below estimated fair value.